Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Dysrhythmias III: Characteristics of Dysrhythmias
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 1, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
E Rosato1, L Tubani1, A Gigante1
1Department of Clinical Medicine, Clinical Immunology Unit, Scleroderma Center, Sapienza University of Rome, Italy.
No abstract available in PubMed .